Patents by Inventor Mark C. Glassy

Mark C. Glassy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ENHANCED DELIVERY OF DRUGS TO THE BRAIN
    Publication number: 20210269513
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Application
    Filed: March 10, 2021
    Publication date: September 2, 2021
    Inventors: Mark C. Glassy, Rishab K Gupta
  • Enhanced delivery of drugs to the brain
    Patent number: 11028155
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Grant
    Filed: September 9, 2016
    Date of Patent: June 8, 2021
    Assignee: Nascent Biotech, Inc.
    Inventors: Mark C. Glassy, Rishab K. Gupta
  • ENHANCED DELIVERY OF DRUGS TO THE BRAIN
    Publication number: 20170073400
    Abstract: Compositions and methods related to antibodies or antibody fragments which are capable of crossing the blood brain barrier are provided.
    Type: Application
    Filed: September 9, 2016
    Publication date: March 16, 2017
    Inventors: Mark C. Glassy, Rishab K. Gupta
  • Antibodies that recognize hyperproliferative cells and methods of making and using same
    Patent number: 7829677
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: September 25, 2008
    Date of Patent: November 9, 2010
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • ANTIBODIES THAT RECOGNIZE HYPERPROLIFERATIVE CELLS AND METHODS OF MAKING AND USING SAME
    Publication number: 20090087442
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Application
    Filed: September 25, 2008
    Publication date: April 2, 2009
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Antibodies that recognize hyperproliferative cells and methods of making and using same
    Patent number: 7446178
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: December 6, 2006
    Date of Patent: November 4, 2008
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Antibodies that recognize hyperproliferative cells and methods of making and using same
    Patent number: 7238353
    Abstract: The invention relates to antibodies that bind to antigens, such as antigens associated with hyperproliferating cells, and methods of treating hyperproliferative disorders. The invention antibodies are useful for treating hyperproliferative disorders, such as neoplasia.
    Type: Grant
    Filed: September 11, 2003
    Date of Patent: July 3, 2007
    Assignee: Shantha West, Inc.
    Inventors: Subhra Chakrabarti, Sonjoy Mukerjee, Mark C. Glassy
  • Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor
    Publication number: 20020098581
    Abstract: Carcinoma associated antigen (SK1) and monoclonal antibodies and methods for detecting and ameliorating malignant disease. The monoclonal antibodies are specifically reactive with epitopes present on SK1.
    Type: Application
    Filed: December 20, 2001
    Publication date: July 25, 2002
    Inventors: Mark C. Glassy, Helena R. Chang, Keiji Koda
  • Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and uses therefor
    Patent number: 6355444
    Abstract: Carcinoma associated antigen (SK1) and monoclonal antibodies and methods for detecting and ameliorating malignant disease. The monoclonal antibodies are specifically reactive with epitopes present on SK1.
    Type: Grant
    Filed: June 10, 1997
    Date of Patent: March 12, 2002
    Assignee: Viventia Biotech Inc.
    Inventors: Mark C. Glassy, Helena R. Chang, Keiji Koda
  • Human-Human CLNH5-specific antibodies
    Patent number: 6090924
    Abstract: CLNH5-specific hybridomas, human monoclonal antibodies and their uses are provided. The antibodies distinguish a human neoplastic cell from a normal cell of the same tissue type. The monoclonal antibodies find use in therapy and diagnosis, both in vitro and in vivo.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: July 18, 2000
    Assignee: The Regents of the University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Hideaki Hagiwara, Yoshihide Hagiwara
  • Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies
    Patent number: 6051387
    Abstract: CLNH5 and CLNH11-specific hybridomas, human monoclonal antibodies and their uses are provided. The antibodies distinguish a human neoplastic cell from a normal cell of the same tissue type. The monoclonal antibodies find use in therapy and diagnosis, both in vitro and in vivo.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 18, 2000
    Assignee: The Regents of the University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Hideaki Hagiwara, Yoshihide Hagiwara
  • CLNH11-specific antibodies
    Patent number: 6051693
    Abstract: CLNH11-specific hybridomas, human monoclonal antibodies and their uses are provided. The antibodies distinguish a human neoplastic cell from a normal cell of the same tissue type. The monoclonal antibodies find use in therapy and diagnosis, both in vitro and in vivo.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 18, 2000
    Assignee: The Regents of the University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Hideaki Hagiwara, Yoshihide Hagiwara
  • Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions
    Patent number: 6051229
    Abstract: CLNH5 and CLNH11 specific hybridomas, human monoclonal antibodies and their uses are provided. The antibodies distinguish a human neoplastic cell from a normal cell of the same tissue type. The monoclonal antibodies find use in therapy and diagnosis, both in vitro and in vivo.
    Type: Grant
    Filed: May 18, 1995
    Date of Patent: April 18, 2000
    Assignee: The Regents of the University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Hideaki Hagiwara, Yoshihide Hagiwara
  • Carcinoma associated antigen (SK1) monoclonal antibodies against SK1, methods of producing these antibodies and use therefor
    Patent number: 5637493
    Abstract: Carcinoma associated antigen (SK1) and monoclonal antibodies and methods for detecting and ameliorating malignant disease. The monoclonal antibodies are specifically reactive with epitopes present on SK1.
    Type: Grant
    Filed: February 24, 1994
    Date of Patent: June 10, 1997
    Assignees: Sci-Clone, Inc., The Regents of the University of California
    Inventors: Mark C. Glassy, Helena R. Chang, Keiji Koda
  • Human-human hybridomas for neoplasms
    Patent number: 5286647
    Abstract: Novel hybridomas, human monoclonal antibodies and their uses are provided. The antibodies distinguish a human neoplastic cell from a normal cell of the same tissue type. The monoclonal antibodies find use in therapy and diagnosis, both in vitro and in vivo.
    Type: Grant
    Filed: October 23, 1987
    Date of Patent: February 15, 1994
    Assignee: University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Ideaki Hagiwara, Yoshihide Hagiwara
  • Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells
    Patent number: 4761377
    Abstract: Human-human hybrid cell lines that synthesize and secrete monoclonal antibodies against antigenic determinants on cancer cells, generated by fusing a human lymphoblastoid B cell line to human lymphocytes, and therapeutic and diagnostic uses of the monoclonal antibodies in both cancer treatment and research is disclosed.
    Type: Grant
    Filed: October 15, 1984
    Date of Patent: August 2, 1988
    Assignee: The Regents of the University of California
    Inventors: Mark C. Glassy, Charles Surh
  • Human-human hybridoma, CLNH5
    Patent number: 4618577
    Abstract: Novel hybridomas, human monoclonal antibodies, and their uses are provided. Specifically CLNH5 is a human-human hybridoma which secretes IgM monoclonal antibodies specific for cervical of carcinomas. The monoclonal antibodies can find use in therapy and diagnosis, both in vitro and in vivo.The hybridoma CLNH5 was deposited at the A.T.C.C. for patent purposes as defined in M.P.E.P. 608.01(p) on Jan. 28, 1983 and given A.T.C.C. Accession No. HB8206.
    Type: Grant
    Filed: February 9, 1983
    Date of Patent: October 21, 1986
    Assignee: The Regents of The University of California
    Inventors: Harold H. Handley, Mark C. Glassy, Yoshihide Hagiwara, Hideaki Hagiwara